Rapid response to cyclosporine therapy and sustained remission in large granular lymphocyte leukemia.
Gabor
E P
EP
Mishalani
S
S
Lee
S
S
D000328:Adult; D000380:Agranulocytosis / Q000150:complications / Q000628:therapy; D003131:Combined Modality Therapy; D016572:Cyclosporine / Q000627:therapeutic use*; D003907:Dexamethasone / Q000627:therapeutic use; D005260:Female; D015333:Gene Rearrangement, beta-Chain T-Cell Antigen Receptor; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007239:Infections / Q000150:complications; D015459:Leukemia-Lymphoma, Adult T-Cell / Q000150:complications / Q000188:drug therapy*; D012074:Remission Induction
D007155:Immunologic Factors; D007166:Immunosuppressive Agents; D003907:Dexamethasone; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D016572:Cyclosporine